Editorial
Therapeutic strategies for type 2 diabetes mellitus patients with very high HbA1c: is insulin the only option?
Abstract
Approximately 40% of patients with type 2 diabetes mellitus (T2DM) will experience microvascular complications (1), and T2DM is the leading cause of renal failure and blindness in western countries (2-4).
